Acetylcysteine USP

Composition : Mukof Tablet : Each Dispersible Tablet Contains Acetylcysteine USP 600mg.

Indications : It is indicated as an adjunctive treatment for patients with abnormal, viscid or inspissated mucus secretions associated with conditions such as

· Acute and chronic bronchopulmonary disorders (e.g. pneumonia, bronchitis, emphysema, tracheobronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis, primary amyloidosis of the lung)

· Atelectasis caused by mucus obstruction

· Pulmonary complications of cystic fibrosis

· Pulmonary complications of thoracic and cardiovascular surgery &

· Post-traumatic chest conditions. It is effective in all respiratory airways disease causing formation of a dense secretion that cannot be or can only partially be expectorated such as acute and chronic bronchitis, laryngitis, sinusitis, tracheitis, influenza & bronchial asthma. Acetylcysteine is also indicated in the treatment of Paracetamol overdose. Treatment option is optimal if given within 8 hours of Paracetamol ingestion.

Dosage and administration : Adults & children above 6 years of age: 1 tablet daily (Preferably in the evening). The duration of treatment should be 5-10 days in acute treatment. In Paracetamol overdose: Initially 140 mg/kg, followed by 70 mg/kg every 4 hours for an additional 17 doses. Dissolve 1 tablet in a glass of water (200 ml) to drink. Or, as directed by the registered physician.

Use in Pregnancy and lactation: Pregnancy category B. Caution should be taken in case of pregnancy & lactation while using Acetylcysteine.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.